Figure 1.
Figure 1. Phenotypic analysis of NKp46, NKp30, and NKG2D. Representative examples of double-color flow cytometric analysis within the lymphocyte compartment of PBMCs. Cross-reactivity of mAbs specific to human NKp46 (top row), NKp30 (middle row), and NKG2D (bottom row) along with anti-CD3 and anti-HLA-DR mAbs in a human donor (left column), and in rhesus (middle column), and pigtailed (right column) macaques. The cells with the brightest mean fluorescence intensity in the lower right quadrant of each rhesus and pigtailed monkey dot plot corresponded to the HLA-DRpos (or CD20pos) lymphocyte subset that identified the B-cell population. The absolute percentage of CD3neg/HLA-DRneg (NK) lymphocytes positive for the relevant receptor is highlighted in bold in the upper left quadrant of the cross bar in the upper right quadrant of each dot plot. The relative percentage of total CD3neg/HLA-DRneg (NK) population positive for NKp46, NKp30, and NKG2D is indicated in gray in the upper left quadrant of each dot plot.

Phenotypic analysis of NKp46, NKp30, and NKG2D. Representative examples of double-color flow cytometric analysis within the lymphocyte compartment of PBMCs. Cross-reactivity of mAbs specific to human NKp46 (top row), NKp30 (middle row), and NKG2D (bottom row) along with anti-CD3 and anti-HLA-DR mAbs in a human donor (left column), and in rhesus (middle column), and pigtailed (right column) macaques. The cells with the brightest mean fluorescence intensity in the lower right quadrant of each rhesus and pigtailed monkey dot plot corresponded to the HLA-DRpos (or CD20pos) lymphocyte subset that identified the B-cell population. The absolute percentage of CD3neg/HLA-DRneg (NK) lymphocytes positive for the relevant receptor is highlighted in bold in the upper left quadrant of the cross bar in the upper right quadrant of each dot plot. The relative percentage of total CD3neg/HLA-DRneg (NK) population positive for NKp46, NKp30, and NKG2D is indicated in gray in the upper left quadrant of each dot plot.

Close Modal

or Create an Account

Close Modal
Close Modal